Earningsreport

Q3/2018 9/30/2018 EPS -0.140 ZacksConsensus -0.140 ActVsEst 0.000 - In-Line

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com